India  

Pfizer COVID vaccine results show strong immune response in children 6 months to 5 years

Video Credit: Rumble - Duration: 02:39s - Published
Pfizer COVID vaccine results show strong immune response in children 6 months to 5 years

Pfizer COVID vaccine results show strong immune response in children 6 months to 5 years

Pfizer and BioNTech announced an analysis that showed that their three-dose coronavirus vaccine regimen indicated a strong immune response in children 6 months to 5 years of age.

The analysis reported an efficacy rate of more than 80 percent, and what this could mean for the future of vaccinating toddlers.


You Might Like


Related videos from verified sources

Philippines: Schools remain close after two years as hopes of education fade away | Oneindia News [Video]

Philippines: Schools remain close after two years as hopes of education fade away | Oneindia News

Three months after the Philippines reopened from a long COVID-19 lockdown, most schools remain shut. Less than a quarter of children have returned to classes – and those left behind are watching..

Credit: Oneindia     Duration: 03:16Published
FDA Sets June Date for Pediatric Vaccine Authorization Review [Video]

FDA Sets June Date for Pediatric Vaccine Authorization Review

The date for the U.S. Food and Drug Administration to review Moderna’ Inc’s emergency authorization request to administer the Covid-19 vaccine to children aged 6 months to 5 years has been..

Credit: Veuer     Duration: 00:59Published
Pfizer’s 3-Dose Vaccine 80% Effective Against Omicron Infection for Youngest Children [Video]

Pfizer’s 3-Dose Vaccine 80% Effective Against Omicron Infection for Youngest Children

Pfizer’s 3-Dose Vaccine , 80% Effective Against Omicron, Infection for Youngest Children. ABC News reports new data shows Pfizer's 3-dose vaccine is 80% effective against omicron infections in..

Credit: Wibbitz Top Stories     Duration: 01:30Published